Literature DB >> 12222978

Acute stroke therapy: beyond i.v. tPA.

Anthony J Furlan1.   

Abstract

Although intravenous tissue plasminogen activator (i.v. tPA) has been approved for treating acute ischemic stroke, it must be given within 3 hours of stroke onset and only after ruling out hemorrhagic stroke by computed tomography. Several medical centers are turning to angiography to guide intra-arterial infusion of thrombolytic agents and mechanical endovascular interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222978     DOI: 10.3949/ccjm.69.9.730

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  6 in total

Review 1.  Mechanical recanalization for acute ischemic stroke.

Authors:  Shinichi Nakano; Shimichiro Wakisaka
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population.

Authors:  Shuichi Suzuki; Jeffrey L Saver; Phillip Scott; Reza Jahan; Gary Duckwiler; Sidney Starkman; Yafang Su; Chelsea S Kidwell
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

3.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

4.  A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Authors:  Bopanna I Kalappa; Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

5.  A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.

Authors:  Fen Sun; Kunlin Jin; Victor V Uteshev
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

6.  Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model.

Authors:  R Christian Crumrine; Victor J Marder; G McLeod Taylor; Joseph C Lamanna; Constantinos P Tsipis; Philip Scuderi; Stephen R Petteway; Vikram Arora
Journal:  Exp Transl Stroke Med       Date:  2011-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.